Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:33:54.605Z.
Calculation as of: 2026-10-06T16:33:54.605Z.
Quote observation: 2026-10-06T16:30:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5a9e17458a879267a616e624bc5dc95fe16f3f590d16343b45edf8fcc71148c1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$355.36M
Free Cash Flow Yield
N/A
TTM Avg
15.24%
3Y Avg
15.24%
5Y Avg
15.24%
Market Cap
$354.45M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$353.30M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$359.33M
Free Cash Flow Yield
N/A
TTM Avg
3.10%
3Y Avg
3.51%
5Y Avg
4.59%
Market Cap
$359.53M
Free Cash Flow Yield
45.78%
TTM Avg
52.29%
3Y Avg
21.98%
5Y Avg
21.35%
Market Cap
$349.40M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$374.75M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocugen, Inc. (OCGN) | $359.46M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $355.36M | N/A | 15.24% | 15.24% | 15.24% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $354.45M | N/A | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $353.30M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $359.33M | N/A | 3.10% | 3.51% | 4.59% |
| Embecta Corp. (EMBC)vs › | $359.53M | 45.78% | 52.29% | 21.98% | 21.35% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.40M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $363.54M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $374.75M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $332.29M | N/A | 0.01% | 0.01% | 0.01% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
